CSS
KYTX icon

Cubist Systematic Strategies’s Kyverna Therapeutics KYTX Stock Holding History

Cubist Systematic Strategies’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$123K Sell
20,446
-124,177
-86% -$496K ﹤0.01% 2750
2025
Q2 		$444K Buy
144,623
+75,995
+111% +$188K ﹤0.01% 2291
2025
Q1 		$132K Buy
68,628
+16,267
+31% +$48.1K ﹤0.01% 2596
2024
Q4 		$196K Sell
52,361
-16,597
-24% -$79.5K ﹤0.01% 2576
2024
Q3 		$337K Buy
+68,958
New +$532K ﹤0.01% 2379
2024
Q2 		– Sell
-2,775
Closed -$68.9K – 4187
2024
Q1 		$68.9K Buy
+2,775
New +$77.4K ﹤0.01% 3330

Other funds holding KYTX

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MPM
MBB Public Markets Chicago, Illinois $839M AUM 20.48% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cubist Systematic Strategies's KYTX Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Kyverna Therapeutics (KYTX) stake by 86% in Q3 2025, selling an estimated $496K and leaving 20,446 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

Cubist Systematic Strategies first reported a position in KYTX in Q1 2024 and has held it in 6 quarters since. The position peaked at $444K in Q2 2025. 75 funds tracked by Wall St. Rank hold KYTX as of Q3 2025.

  • Cubist Systematic Strategies held 20,446 shares of Kyverna Therapeutics worth $123K as of Q3 2025.
  • Cubist Systematic Strategies sold 124,177 Kyverna Therapeutics shares in Q3 2025, an estimated $496K.
  • Kyverna Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2750 holding.
  • Cubist Systematic Strategies first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • Cubist Systematic Strategies's Kyverna Therapeutics position peaked at $444K in Q2 2025.
  • 75 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.